Our efforts to battle the Coronavirus (COVID-19)

Omega Bio-tek is assisting scientists, researchers and healthcare workers around the globe in accelerating the screening and detection of the novel coronavirus disease, COVID-19. We are supporting several Laboratory Developed Tests (LDTs) by providing high-throughput, automated viral nucleic acid extraction methodologies. To meet the exceptional and immediate need for supplies, Omega Bio-tek created a more robust kit, Mag-Bind® Viral RNA Xpress Kit, and has the capacity to support 6 million RNA extractions per month. Omega Bio-tek is working alongside scientists in providing extraction technologies to expert technical and automation support in quickly establishing pathogen detection workflows to curtail the escalating spread of COVID-19.  

High Throughput Viral Nucleic Acid Extraction

High quality RNA extraction

Mag-Bind® Viral RNA Xpress Kit

  • Isolation of viral RNA from swabs in viral transport media
  • Fully automatable and ready-to-load scripts for:
    – KingFisher™, BioSprint®, and MagMAX® 96:  96 samples
    – Hamilton MagEx STARlet:  96 samples in ~1 hr 45 min.
    – Hamilton Microlab® STAR™: (4×96) 384 samples in ~3 hr
    – Hamilton Microlab VANTAGE®: (4X96) 384 samples in ~75 min
    – Tecan Fluent® Automated Workstation 1080:
    (4×96) 384 samples ~75 min
  • Adaptable to other liquid handling platforms
  • Dedicated technical and application support to expedite setup and validation time
  • No backorder
  • Same or next-day shipping in the US and EU

6000000 RNA EXTRACTIONS PER MONTH

With the new Mag-Bind Viral RNA Xpress Kit, Omega Bio-tek is able to deliver a robust and reliable extraction product and triple production capacity to produce up to 6 million RNA extractions per month.

OVER 50000000 

Viral RNA extractions shipped.

Omega Bio-tek is committed to supporting laboratories and researchers worldwide to combat COVID-19. Reach out to one of our sales representatives today.

Detection of Synthetic SARS-CoV-2 virus control following RT-qPCR

Figure 1. 1×105 copies of synthetic SARSCoV-2 was spiked into a 200 μL sample containing 2000 HEK293 cells. Viral nucleic acids were extracted following the recommended protocol from Mag-Bind® Viral RNA Xpress Kit (M6219). 4 and 8 μL of template was used in a 20 μL SYBR Greenlabeled RT-qPCR reaction. The average Ct values obtained are shown on the left. The Ct difference between the two template 30.89 amounts is ~1 indicating no qPCR inhibition.

Patients Choice Laboratories Finds COVID-19 Testing Solutions During the Pandemic with Omega Bio-tek’s Viral RNA Extraction Kit.
Read how Omega Bio-tek helped Patients Choice Laboratories overcome viral RNA extraction kit shortages for COVID-19 testing and helped them gain their Emergency Use Authorization (EUA) from the FDA.

Saliva as a Diagnostic Tool for COVID-19

A Proof-of-Concept Study

A comprehensive extraction-based workflow from collection to detection

To combat a fast-evolving global pandemic like COVID-19, it is essential to develop rapid and accurate diagnostic tests with a quick turnaround time. Recently, saliva has emerged as a viable alternate sample source to nasopharyngeal swabs and has shown to have greater detection sensitivity of SARS-CoV-2, as well as consistency throughout the course of infection. Saliva collection is non-invasive, can be self-administered in the convenience of one’s home eliminating the exposure risk to healthcare workers, and reduces the overall burden on swab and personal protective equipment supplies.